Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Elsevier Provides Access to Reaxys® for Five Czech Universities to Optimize their Research in Chemistry

June 3, 2013

PRAGUE, June 3, 2013 /PRNewswire/ –

5-Year Access Agreement Supported by the European Structural Funds’ Operational
Framework Program for Research, Development and Innovation

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, today announced it has provided access to
Reaxys [http://www.elsevier.com/reaxys ], an online workflow solution for research
chemists, for five Czech universities: the University of Pardubice, the Masaryk
University, the Palacky University in Olomouc, the Tomas Bata University in Zlin and the
University of Veterinary and Pharmaceutical Sciences Brno. The 5-year access agreement is
supported by the European Structural Funds (ESF) through their Operational Framework
Program for Research, Development and Innovation.

“The Czech Republic does not have an optimal solution to support the need for
sustainable access to high quality global scientific research information for all its
universities,” said Prof. Ing. Miroslav Ludwig, CSc, Rector of the University of
Pardubice. “Funding from European Structural Funds to help secure access to basic
information infrastructure in chemistry, chemical engineering and other related fields
connected with sustainable development, opens doors to change this situation”.

Ms. Prochaskova, project coordinator of the Chemical Electronic Information Resources
for R&D project at the University Pardubice said, “Reaxys’ content includes some of the
most important information resources for chemistry and related fields. We are very pleased
that access to Reaxys forms an essential part of the project and has been secured for
these five Czech universities for the next five years.”

Lucie Vavrikova, Elsevier’s Country Manager for Czech Republic added, “We are very
happy to support these universities by providing them with access to Reaxys. It is also
worth mentioning that financing from the European Structural Funds to expand access to
electronic resources such as Reaxys could also support other Central and Eastern European
countries in their desire to improve their research performance.”

Reaxys is a unique workflow solution for researchers across all chemistry related
domains. It is a key pillar of Elsevier Life Science Solutions
[http://www.elsevier.com/online-tools/life-science-solutions ], a suite of interoperable,
domain-specific workflow solutions.

About Reaxys(R)

Reaxys(R) is a workflow solution for research chemists. Offering a wealth of
experimentally validated information, Reaxys(R) combines reaction and substance data in
organic, organometallic, inorganic and physical chemistry with synthesis planning.
Researchers can get the information they need in a single overview, from source
publications carefully selected for their importance and relevance to research chemists.
Elsevier continues to engage with the chemistry community to ensure that Reaxys(R)
continues to reflect how chemists think and work. For more information please visit Reaxys
[http://www.elsevier.com/reaxys ].

Reaxys(R) and the Reaxys(R) trademark are owned and protected by Reed Elsevier
Properties SA and used under license.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.elsevier.com/reaxys ], ClinicalKey
[https://www.clinicalkey.com ] and Mosby’s Suite [http://www.confidenceconnected.com ],
which enhance the productivity of science and health professionals, and the SciVal suite
[http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which help
research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc
[http://www.reedelsevier.com/Pages/Home.aspx ], a world leading provider of professional
information solutions. The group employs more than 30,000 people, including more than
15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies,
Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam
and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam:
REN; New York: RUK and ENL.

        Media contact
        Agata Jablonka
        Elsevier
        +49-172-6273-978
        a.jablonka@elsevier.com

SOURCE Elsevier


Source: PR Newswire